Sudarshan Chemical Industries (506655) Q1 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 24/25 earnings summary
1 Oct, 2026Executive summary
Board changes include retirements and new appointments, aiming to strengthen governance and expertise, with new independent directors effective August 2024.
Achieved highest ever operative revenue and EBITDA in FY24, with sales growing at a 10% CAGR and operating profit at 11% CAGR since FY11, reflecting a focused pigment business strategy.
Achieved a long-term credit rating upgrade to AA Stable from AA- Stable by India Ratings, reflecting improved business profile and financial health.
Received EcoVadis Gold Rating, placing in the top 3 percentile of the chemical sector for ESG performance, and a 'B' rating from CDP for climate change and water security.
Unaudited standalone and consolidated financial results for the quarter ended 30 June 2024 were approved by the Board on 2 August 2024, with compliance confirmed by statutory auditors.
Financial highlights
Consolidated income from operations for Q1 FY25 was ₹634 crore, up 4% year-on-year.
EBITDA for Q1 FY25 increased 16% year-on-year to ₹81 crore, with margin at 12.7%.
Profit after tax for Q1 FY25 was ₹29 crore, up 38% year-on-year, with margin at 4.6%.
Earnings per share for Q1 FY25 stood at ₹4.3, compared to ₹3.0 in Q1 FY24.
Q1 FY24 profit was significantly boosted by a one-time land sale; Q1 FY25 results reflect normalized operations.
Outlook and guidance
Management expects gross margins to remain in the current range, supported by stable raw material prices and growth in specialty pigments.
Capex program underway to drive future growth and EBITDA improvement, with a focus on expanding the specialty segment and product portfolio.
Capacity utilization guidance may be achieved in three years instead of four, with no immediate need for new CapEx; future expansions to be brownfield.
The Board recommended a final dividend of ₹1.00 per share for FY24, in addition to the interim dividend of ₹3.60 per share, totaling ₹4.60 per share for the year.
Continued emphasis on sustainability, operational efficiency, and deeper penetration in international markets.
Latest events from Sudarshan Chemical Industries
- Heubach acquisition adds global scale, with full benefits targeted within two years.506655
M&A announcement - Record pigment sales lifted margins as Heubach acquisition advanced.506655
Q2 24/25 - Q3 FY25 saw strong revenue growth, margin gains, and progress on the Heubach acquisition despite costs.506655
Q3 24/25 - Heubach lifts FY25 sales and adjusted EBITDA, with profitability targets hinging on integration.506655
Q4 24/25 - Q1 FY26 revenue rose to ₹2,507 crore with EBITDA up, but margins and net profit ratio declined.506655
Q1 25/26 - Q2 sales grew despite destocking; Heubach guidance fell as integration advanced.506655
Q2 25/26 - Weak demand drove a consolidated loss, while cost savings and restocking signal recovery.506655
Q3 25/26 - Q4 growth, acquired-group recovery and debt reduction support FY27 plans amid cost risks.506655
Q4 25/26 - Q1 FY27 saw robust revenue, EBITDA, and profit growth, with improved capital efficiency and restructuring.506655
Q1 26/27